AF
NVIV

Allworth Financial’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Allworth Financial’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$1 – 3721
2023
Q4 		$1 Hold
1
– – ﹤0.01% 3447
2023
Q3 		$2 Hold
1
– – ﹤0.01% 3427
2023
Q2 		$2 Hold
1
– – ﹤0.01% 3244
2023
Q1 		$2 Buy
+1
New +$2 ﹤0.01% 3175

Other funds holding NVIV

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VL
Vima LLC Troy, Michigan $103M AUM

Allworth Financial's NVIV Position: Q1 2024 in Review

Allworth Financial sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q1 2024, closing a stake of 1 share — an estimated $1 sold.

Allworth Financial first reported a position in NVIV in Q1 2023 and held it in 4 quarters. The position peaked at $2 in Q3 2023. 4 funds tracked by Wall St. Rank hold NVIV as of Q1 2024.

  • Allworth Financial reported no remaining InVivo Therapeutics Holdings Corp position as of Q1 2024 after selling out during the quarter.
  • Allworth Financial sold 1 InVivo Therapeutics Holdings Corp share in Q1 2024, an estimated $1.
  • Allworth Financial first reported a position in InVivo Therapeutics Holdings Corp in Q1 2023 and held it in 4 quarters.
  • Allworth Financial's InVivo Therapeutics Holdings Corp position peaked at $2 in Q3 2023.
  • 4 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2024.

Based on Allworth Financial's 13F filing for Q1 2024, filed 25 Apr 2024.